US Patent Issued to LDN Pharma on Dec. 16 for "Method of monitoring treatment" (British Inventor)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,663, issued on Dec. 16, was assigned to LDN Pharma Ltd. (London).

"Method of monitoring treatment" was invented by Wai Liu (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a method for monitoring the treatment of a subject undergoing therapy with an active that is naltrexone or a metabolite or analogue thereof, comprising: measuring the gene expression profile of any of the genes listed in Table 1 or Table 2, in a sample of CD3+ cells obtained from the subject undergoing treatment; wherein if the expression of any of the genes in Table 1 is increased compared to a control, or if any of the genes listed in Table 2 is de...